Microscopic Polyangiitis Following mRNA COVID-19 Vaccination: A Case Reportopen access
- Authors
- So, Daeyoung; Min, Kyueng-Whan; Jung, Woon Yong; Han, Sang-Woong; Yu, Mi-Yeon
- Issue Date
- May-2022
- Publisher
- Korean Academy of Medical Science
- Keywords
- Anti-myeloperoxidase autoantibody; Anti-neutrophil cytoplasmic antibody (anca); Covid-19; Covid-19 vaccine; Microscopic polyangiitis
- Citation
- Journal of Korean Medical Science, v.37, no.19, pp.1 - 6Mi-Yeon
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- Journal of Korean Medical Science
- Volume
- 37
- Number
- 19
- Start Page
- 1
- End Page
- 6Mi-Yeon
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/170234
- DOI
- 10.3346/jkms.2022.37.e154
- ISSN
- 1011-8934
- Abstract
- Coronavirus disease 2019 (COVID-19) is one of the most widespread viral infections in human history. As a breakthrough against infection, vaccines have been developed to achieve herd immunity. Here, we report the first case of microscopic polyangiitis (MPA) following BNT162b2 vaccination in Korea. A 42-year-old man presented to the emergency room with general weakness, dyspnea, and edema after the second BNT162b2 vaccination. He had no medical history other than being treated for tuberculosis last year. Although his renal function was normal at last year, acute kidney injury was confirmed at the time of admission to the emergency room. His serum creatinine was 3.05 mg/dL. Routine urinalysis revealed proteinuria (3+) and hematuria. When additional tests were performed for suspected glomerulonephritis, the elevation of myeloperoxidase (MPO) antibody (38.6 IU/mL) was confirmed. Renal biopsy confirmed pauci-immune anti-neutrophil cytoplasmic antibody (ANCA)-related glomerulonephritis and MPA was diagnosed finally. As an induction therapy, a combination of glucocorticoid and rituximab was administered, and plasmapheresis was performed twice. He was discharged after the induction therapy and admitted to the outpatient clinic 34 days after induction therapy. During outpatient examination, his renal function had improved with serum creatinine 1.51 mg/dL. We suggest that MPA needs to be considered if patients have acute kidney injury, proteinuria, and hematuria after vaccination.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
- 서울 의과대학 > 서울 병리학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/170234)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.